-
Emerging Therapies Shine Hope on Small Cell Lung Cancer Treatment
28 Jan 2025 23:22 GMT
… lung cancer (SCLC) represents about 15% of all lung cancer … translation of small-cell lung cancer therapeutics. Cancers (Basel … -stage small-cell lung cancer: randomized, double-blind … carboplatin, and etoposide in extensive-stage small-cell lung cancer …
-
AstraZeneca receives positive NICE recommendations for lung cancer treatment
25 Jan 2025 05:40 GMT
… carboplatin or cisplatin for adults with untreated extensive-stage small cell lung cancer … (ES-SCLC).
Durvalumab in lung cancer
Lung cancer is … in lung cancer
NSCLC is the most common lung cancer, … is significant, with lung cancer costing the UK …
-
Two AstraZeneca Treatments Recommended for Lung Cancer Patients in England and Wales
23 Jan 2025 23:13 GMT
… Extensive-stage small cell lung cancer is a devastating diagnosis … durvalumab with etoposide plus carboplatin or cisplatin.”
Osimertinib … is fantastic news for lung cancer patients,” Tom Keith-Roach … NICE Recommendations for Lung Cancer Patients Across England …
-
AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi
22 Jan 2025 18:03 GMT
… for the use of its lung cancer treatments, Tagrisso (osimertinib) … chemotherapy etoposide and either carboplatin or cisplatin for the … to chemotherapy alone.
Lung cancer remains the most common … the combination of its lung cancer drugs Lazcluze (lazertinib) …
-
Non-Small Cell Lung Cancer Pipeline, Clinical Trials, Emerging Drugs Approvals and Companies | DelveInsight
22 Jan 2025 10:41 GMT
… Lung Cancer treatment.
• The leading Non-Small Cell Lung Cancer … , Cemiplimab, SKB264, Carboplatin, Osimertinib, and others … Lung Cancer Clinical Trials Assessment
Non-Small-Cell Lung cancer … lung cancer.
Learn more about Non-Small Cell Lung Cancer …
-
AstraZeneca receives positive recommendations for lung cancer treatments
22 Jan 2025 13:13 GMT
… Care Excellence (NICE) for its lung cancer treatments, Imfinzi and Tagrisso, benefiting … combination with etoposide plus either carboplatin or cisplatin has been endorsed … , “This is fantastic news for lung cancer patients. These NICE decisions represent …
-
AstraZeneca receives NICE recommendations for lung cancer drugs Tagrisso and Imfinzi
22 Jan 2025 12:39 GMT
… ) for use of its lung cancer drugs Tagrisso (osimertinib) and … 3A non-small cell lung cancer (NSCLC) whose tumours … with etoposide plus either carboplatin or cisplatin to treat … lung cancer (SCLC).
Approximately 49,200 people are diagnosed with lung cancer …
-
Clinical Significance of the Peripheral Blood Neutrophil-to-Lymphocyte Ratio in Predicting Chemotherapy Outcomes for Small Cell Lung Cancer
22 Jan 2025 09:42 GMT
… stage III non-small-cell lung cancer. Lung Cancer. 2022;163:35–41 … limited-stage small-cell lung cancer. Transl Lung Cancer Res. 2021;10 … et al. Cisplatin or carboplatin? Neutrophil to lymphocyte ratio … advanced non-small cell lung cancers treated with anti-PD …
-
EU approves endometrial, lung cancer drugs from GSK and J&J
21 Jan 2025 14:22 GMT
… that Jemperli (dostarlimab) given with carboplatin and paclitaxel chemotherapy achieved a … treatment for this type of lung cancer, and will be pivotal in …
-
Roles of SPOCK1 in the Formation Mechanisms and Treatment of Non-Small-Cell Lung Cancer and Brain Metastases from Lung Cancer
15 Jan 2025 20:05 GMT
… target for osimertinib-resistant lung tumors. In recent years … non-small cell lung cancers and long-term … squamous non-small cell lung cancer. Lung Cancer. 2019;129:35 … carboplatin and pemetrexed for patients with advanced nonsquamous non-small-cell lung cancer …
About
© 1995-2025